News ToDay

Corona Vaccine: Desi Corona Vaccine ‘Covaxin’ will have to wait for approval from WHO and wait! screw stuck here

Bharat Biotech’s vaccine Covaxin will have to wait more for the emergency use approval of the World Health Organization (WHO).

Bharat Biotech (Bharat Biotech) K Vaccine Covaccine (Covaxin) to the world health organization (WHO) Will have to wait more for the emergency use approval. NDTV Quoting sources, has told that the Kovid-19 vaccine developed by Hyderabad-based Bharat Biotech is for Covaccine. WHO The approval has been deferred due to technical questions raised by the health organization.Also Read – Delta Variant: The Delta variant of Corona has spread to 185 countries so far, but there has also been a decline in new cases – WHO

NDTV According to sources, more technical questions have been sent to vaccine maker Bharat Biotech. Please tell that without the approval of WHO Covaxin would not be considered a vaccine approved by most countries around the world. Earlier there was news that Covaxin It can get approval from WHO this week. Also Read – Coronavirus Updates: Good News from WHO regarding Corona Virus! Know what was said…

It is known that currently three anti-corona vaccines are being used in India. These include Bharat Biotech’s Covaccine, Serum Institute’s Covishield and Russia’s Sputnik V. Also Read – Historical Achievement! More than 75 crore corona vaccine doses were administered in India, WHO also praised the vaccination campaign

Let us inform that at present emergency use of Bharat Biotech’s vaccine is allowed in India, but so far this vaccine has not been approved by the regulatory body of any western country. Because of this, many countries have not allowed the travel of people who have got the vaccine.

According to a study recently published by the Indian Council of Medical Research (ICMR) in BioRxiv, Bharat Biotech’s Kovid-19 vaccine is effective against the delta plus form of Covaxin corona. The study states that IgG antibodies have been evaluated. In this, the possibility of Kovid-19 has been eliminated in individuals receiving the full dose of BBV 152 vaccine. It evaluated BBV152 vaccines against Delta, Delta AY.1 and B.1.617.3.

.

Show More

Related Articles

Leave a Reply

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker